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Abstract
For decades, many studies have linked maternal smoking to an increased risk of preterm birth. As 
a result, the scientific community has long hypothesized that exposure to environmental tobacco 
smoke (ETS), commonly referred to as second-hand smoke, is also associated with an increased 
risk of preterm birth. Multiple studies have examined this proposed association through different 
strategies and approaches. Recently, a small number of epidemiology studies have examined 
preterm birth trends before and after the implementation of anti-smoking legislation in various 
jurisdictions. We found that these studies have largely revealed a significant trend of decreasing 
population-level preterm birth rates after the implementation of smoking bans. However, most of 
the studies reviewed did not distinguish the impact of maternal smoking from ETS in their 
analyses, making it difficult to specifically evaluate the effects of smoking bans on ETS exposure. 
Other studies have taken the approach of directly measuring maternal ETS exposure and 
associations with preterm birth within particular study populations. In contrast to smoking ban 
studies, the latter group of studies had more inconclusive results. The use of a variety of exposure 
assessment methods ranging from different self-reporting techniques to biomarker measurements 
posed a challenge to compare studies. We evaluated current scientific literature for evidence of an 
association between maternal ETS exposure and risk of preterm birth. We also discuss the 
strengths and weaknesses of the different approaches to study this association, as well as methods 
used for ETS exposure assessment. We propose that more studies, specifically, evaluating rates of 
preterm birth among non-smoking women before and after smoking bans, are needed, as well as 
using better ETS exposure assessments methods in studies measuring maternal ETS exposure.
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Preterm birth is both a common and devastating adverse health outcome with global 
impacts. On average, approximately 11.1% of all babies born globally are classified as 
preterm. In 2010 alone, an estimated 15 million babies were born prematurely worldwide, 
including over half a million in the United States.1 The World Health Organization generally 
defines preterm birth as a woman giving birth before 37 weeks gestation.2 Babies who are 
born prematurely face a myriad of health complications upon arrival which greatly increase 
their likelihood of death. These include factors such as lung immaturity, gastrointestinal 
feeding intolerance, skin problems including the inability to regulate body temperature, 
immune system deficiencies, and cardiovascular, hearing and vision problems.3 
Complications from preterm birth are the leading cause of death in children under the age of 
5.2 These complications are not just limited to the days and weeks after birth. Premature 
babies often face a lifetime of chronic health problems and devastating disabilities, costing 
an estimated twenty-six billion dollars a year in the United States alone.3
ENVIRONMENTAL TOBACCO SMOKE
The scope of the preterm birth problem makes it a pressing global public health issue and as 
a result, extensive research has been conducted on potential causes for many decades. One 
potential cause of preterm birth that has been examined in the past few decades is 
environmental tobacco smoke (ETS). ETS, also known as secondhand smoke or passive 
smoke, is defined as any smoke from a tobacco-containing product that is emitted into the 
ambient air through the exhalation of an active smoker (mainstream smoke) or through the 
burning end of a lit cigarette (side stream smoke). Exposure to ETS primarily occurs in 
indoor environments such as at home, in cars or in restaurants.4 However, it can also occur 
outdoors such as near the entrances of smoke-free buildings or bus stops.4 Although a 
wealth of evidence dating back to the 1950s indisputably links active maternal smoking to 
preterm birth, considerably less research has examined the relationship between ETS and 
preterm birth.5 The comparatively small number of studies examining associations between 
ETS and preterm birth have examined the issue utilizing different strategies and approaches 
(Figure 1).
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As a result of the overwhelming evidence of adverse health outcomes and mortality 
attributed to smoking, in the past several decades a number of different types of smoking 
bans have been implemented across different parts of the world. These regulations vary 
widely in their details, scope, enforcement and geography. For example, some of the bans 
cover only bars and restaurants, while others also include parks, public spaces and 
workplaces. In addition, bans apply to whole countries, individual states, counties or cities.6 
Timing and implementation of the anti-smoking regulations have varied. In Scotland, a 
single ban passed at one point in time and was implemented in phases over the course of 
years.7 In other examples, different bans were passed at different times or a single ban was 
passed and implemented at one time. As the number of smoking bans continues to increase, 
it is necessary to assess the effects of these bans in reducing smoking-related morbidities.
EVIDENCE FROM ANTI-SMOKING LEGISLATION AND PRETERM BIRTH 
STUDIES
Several epidemiology studies have examined the potential association between maternal 
ETS exposure and the risk of preterm birth by using the strategy of evaluating preterm birth 
trends before and after the implementation of anti-smoking legislation locally, regionally, 
and nationally. In order to characterize the results thus far of smoking bans and preterm birth 
studies, we searched PubMed to identify relevant studies. Different combinations of 
keywords were entered into the regular search bar. These keywords included “smoking 
bans,” “anti-smoking legislation,” “tobacco control,” “smoking regulation,” “smoke-free 
legislation,” “preterm birth,” “birth outcomes,” “neonatal outcomes,” “gestation,” and 
“premature.” In addition, we identified studies using citations from the Been et al. meta-
analysis review.6 All studies that examined the associations of anti-smoking laws with 
preterm birth rates were included in the analysis. We identified five studies which are 
discussed here.7–11 In addition to preterm birth, most of the studies included evaluations of 
other outcomes such as low birth weight, small for gestational age, maternal smoking and 
childhood asthma. Only the sections of the studies relevant to the preterm birth outcome 
were evaluated.
Each of the five studies were conducted on populations in northern and western Europe and 
the United States. They encompassed geographical areas ranging from nations (Norway, 
Ireland) to regions (Flanders, Belgium and Scotland) to cities (Pueblo and El Paso, 
Colorado). The earliest smoking ban was implemented in 2003 and the last in 2010. Three of 
the five studies assessed laws with one implementation date that banned smoking in 
workplaces and public places.8–10 One study assessed laws that were passed at the same 
time and were implemented in three phases over the course of four years, also banning 
smoking in work-places and public places.7 One study assessed a law that built upon a 
previous ban on smoking in workplaces and public places by adding bans in restaurants and 
bars.11 The studies all used retrospectively available routine health data collected during and 
after pregnancies to perform their analyses. Interrupted time series and difference-in-
difference study designs were used. All of the studies identified increased odds of preterm 
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birth after the implementation of each ban. Several studies also reported gradual (slope) 
changes in preterm birth rates. These logistic regression models also included adjustment for 
several confounders. The most commonly included confounders in final regression models 
were: parity (4 studies), sex of baby (3 studies), age of mother (3 studies), alcohol 
consumption (2 studies) and marital status (2 studies).7–11
These studies have largely revealed a significant trend of decreasing population-level 
preterm birth rates after the implementation of smoking bans. The results of the five studies 
are summarized in Table 1. Four of the five studies showed overall immediate (step) 
statistically significant reductions in the rates of preterm birth7–10, while the fifth study 
showed a trend towards a reduction that was not significant.11 The largest reduction in the 
overall preterm birth rate category was −25% [95% Confidence Interval: −41.0%, −4.0%] 
reported by Kabiretal.8, while the smallest reduction was −0.59% [95% CI: −2.63%, 
1.49%]7 reported by Cox et al. following the first ban of three implemented over the course 
of the study. Even though Cox et al. reported relatively small, insignificant reductions after 
the first and third bans were implemented, their final model for overall preterm birth rate, 
which included all three bans, was a larger significant reduction of −3.18% [95% CI: 
−5.38%, −0.94%]7. By contrast, Cox et al. reported significant reductions in the spontaneous 
preterm birth rate category following the implantation of each of the three smoking bans, as 
well as a reduction of −3.13% [95% CI: −4.37%, −1.87%] in their final model for the 
spontaneous category (Figure 2)7. In addition to Cox et al., Bhardawaj et al. also reported a 
reduction that was not statistically significant of −2.55% [90% CI: −5.52%, 0.42%].11 Page 
et al., who looked at a city-wide smoking ban in Colorado found a large −23.1% [95% CI: 
−40.1, −1.3]10 reduction in preterm birth rates, while Mackay et al. found a modest overall 
reduction of −11.72% [95% CI: −15.87%, −7.35%].9 Ameta-analysis conducted by Been et 
al. in 2014 is consistent with our finding that these studies have largely revealed a significant 
trend of decreasing preterm birth rates after the implementation of smoking bans. Been et al. 
included data from four of the five studies summarized here in their meta-analysis of over 
1.3 million births.6 They found a significant reduction of −10.4% [95% CI: −18.8%, −0.2%] 
in the rate of preterm births after the implementation of smoking bans.6
A key limitation of this group of studies looking at the effects of smoking bans on preterm 
birth rates is the fact the majority of them were not able to differentiate the effects of the 
bans on active maternal smoking exposure versus second hand exposure because the 
researchers used previously collected health data and had no input into what questionswere 
asked of the mothers.7, 8, 10 Only two of the studies were able to report on preterm birth rates 
for women who never smoked versus current smokers.9, 11 Bhardawaj et al. reported no 
significant reduction for either group (but the stratified estimates were not shown), while 
MacKay et al. showed a significant reduction in preterm birth rates for both current smokers 
and never-smokers.9,11 Interestingly, they reported that never-smokers showed a 3-fold 
greater reduction in preterm births rates at −15.44% [95% CI: −21.02%, −9.47%] than 
current smokers at −5.51% [95% CI: −13.84%, 3.63%].9 This underscores the substantial 
need for more studies that are able to specifically examine the effects of smoking bans on 
non-smoking women. Such studies could use smoking bans as a proxy for reduced ETS 
exposure and eliminate similar exposures that active smokers receive from their direct 
smoking.
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ETS EXPOSURE ASSESSMENT METHODS
In addition to the small group of studies using the smoking ban approach to study changes in 
preterm birth rates at a population level, a considerably larger group of studies have taken 
the approach of directly measuring maternal ETS exposure and associations with preterm 
birth within particular study populations. These studies faced substantial challenges in 
developing methods for accurately measuring ETS exposure among pregnant women.4 
These challenges exist because assessing individual exposure accurately is difficult and 
many individual variables affect bodily absorption and disposition of ETS. A few of these 
challenges include assessing intensity and duration of exposure, repetitive or non-continuous 
exposure, cumulative effects, knowledge of exposure, indoor ventilation and outdoor 
weather patterns.4, 12 Despite these challenges, the number of studies assessing ETS and 
preterm birth has markedly increased since 2000, utilizing methods that have been evolving 
since they were first conceived in the 1960s.
SELF-REPORTING: INTERVIEWS AND QUESTIONAIRES
The most widely used method for assessing exposure to ETS has been through self-
reporting, utilizing either interviews or self-reported questionnaires. The self-reporting 
methodology has many strengths, including its non-invasive nature, its cost-effectiveness and 
feasibility in larger studies and developing countries and its ease of obtaining large amounts 
of information in short periods of time. In particular, recent studies have done a better job 
than older studies of more accurately classifying and stratifying exposure levels over the 
course of the entire pregnancy and categorizing the severity of preterm birth. These efforts 
aim to establish a dose-response relationship, account for confounding, and gain detailed 
information on exposure sources.
Despite the wide spread use of self-reporting, many limitations for this method exist. These 
include early studies using too few simplistic questions about exposure, no classification of 
levels, location, intensity, or duration of ETS exposure, differences in how variables are 
defined and stratified and a wide array of methods for obtaining self-reported 
information.12–17 In addition, in accuracies in self-reporting have led to high 
misclassification rates between non ETS-exposed and ETS-exposed pregnant women as 
shown by studies using biochemical validation of self-reported ETS exposure information.18 
The limitations that exist with using this method alone to classify ETS exposure have 
prompted the development and use of another assessment method, biomarkers.
ETS EXPOSURE MEASUREMENTS: BIOMARKERS
Biomarkers are measurable indicators of the presence of substances or their metabolites in 
the human body.19 In contrast to self-reported exposure information, which can offer 
imprecise information on potential exposure levels, biomarkers provide tangible proof of 
exposure and quantifiable measurements of the amount absorbed into the body from the 
exposure.4 In order for a specific biomarker to provide an accurate and precise quantification 
of an exposure, it should ideally meet several criteria. These criteria include specificity to the 
exposure, a relationship to the specific substance within the exposure that is thought to cause 
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adverse health outcomes, a sufficiently long half-life, and a laboratory technique for 
quantification with a reasonable level of detection.20
Cotinine, the primary metabolite of nicotine, has emerged as both a highly accurate and 
practical biomarker to use when assessing ETS exposure because it has been shown to have 
a high sensitivity and specificity to tobacco smoke.20 Cotinine is a relatively stable molecule 
specific to tobacco smoke exposure. Its half-life is approximately 20 hours, making it 
detectable in serum, saliva, and urine for 3 to 4 days after exposure and in hair for 1–2 
months.21,22 Cotinine, as a metabolite of nicotine, is also readily distributed in all issues, 
which implies that its presence indicates exposure in all compartments of the body.20, 23, 24 
Even early studies confirmed the high correlation of cotinine levels in bodily fluids and 
known tobacco exposure. In a study conducted in 1983, Haley et al. found that daily cotinine 
levels in plasma and saliva samples taken from smokers correlated very highly with the 
number of cigarettes they reported smoking, when compared with another metabolite.25 
Although biomarkers have been shown to be highly effective tools for measuring ETS 
exposure, they alone still cannot solely be used to assess ETS exposure because they do not 
provide any contextual information about the possible sources of ETS exposure or 
information about variables that could confound any associations discovered between ETS 
exposure and preterm birth.20
To address the deficits in both self-reporting and biomarker methodology, the best study 
design that has emerged in the past decade is one that utilizes a combination of both methods 
to capture the most accurate information about ETS exposure.26 Carefully considered and 
detailed questions about ETS exposure and possible confounders are combined with 
biomarker measurements of cotinine in bodily fluids or nicotine in hair. Although the 
combined study design is the gold standard, for very large epidemiology studies and studies 
where biochemical validation is not feasible, well-designed self-reported-based study 
designs are still used and viewed as acceptable. Finally, a few other methods for ETS 
exposure assessment have undergone limited testing but show great potential to detect ETS 
exposure even more precisely and accurately than the methods currently available. One 
method, the use of personal exposure monitoring devices, has been shown to accurately 
capture ETS exposure. However, the technology needs improvement and the costs are 
substantial.4, 20
EVIDENCE FROM DIRECT ETS EXPOSURE ASSESSMENT AND PRETERM 
BIRTH STUDIES
Studies that have taken the approach of directly measuring maternal ETS exposure and 
incidences of preterm birth within particular study population shave largely utilized the 
exposure assessment methods out lined above. In order to characterize the results thus far of 
maternal ETS exposure and preterm birth studies, we searched PubMed to identify relevant 
studies. Different combinations of keywords were entered into the regular search bar. These 
key words included “environmental tobacco smoke,” “ETS,” “passive smoke,” “second hand 
smoke,” “passive tobacco smoke,” “preterm birth,” “birth outcomes,” “neonatal outcomes,” 
“gestation,” and “premature.” Several studies were identified using the works cited section 
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of the Meeker and Benedict review and several of the original research articles.4 All studies 
that examined an association between ETS exposure and preterm birth were included in the 
summary. In addition to the primary predictor and outcome of interest, some of the studies 
included other predictors such as active smoking and other out comes such as birth weight; 
however, only the relevant parts of those studies were reviewed. Ultimately, ten studies were 
included in the analysis.12–17, 26–29
Overall, the studies assessing the association between ETS exposure and preterm birth 
showed inconclusive results. The results are summarized in Table 2. All of the studies except 
Martin and Bracken and Mathai et al. used logistic regression for statistical analysis and 
included variables that could potentially confound any association found between ETS 
exposure and preterm birth. The odd ratios comparing the odds of giving birth prematurely 
among non-ETS exposed versus different levels of ETS exposed pregnant were 
obtained.13–17,26,27,29 Some of the studies such as Martin and Bracken, Crane et al., and 
Kharrazi et al., conducted initial univariate analyses between the individual maternal 
characteristics and ETS exposure status, which were displayed on the distribution tables, in 
order to identify possible confounders. They used t-tests or Wilcoxon sign-ranked tests for 
continuous variables and Chi square or Fisher’s exact tests for categorical variables12, 13, 27. 
The most commonly included confounders were parity, maternal age, BMI, employment 
status, and education level (each of 4 studies), history of pregnancy complications, sex of 
baby, alcohol consumption, and marital status (each of 3 studies).13–17, 26, 27, 29
The earlier studies that used simple self-reporting methodology all showed no significant 
association between ETS exposure and preterm birth.12, 15, 28 The more recent studies that 
use more sophisticated self-reporting methodology showed mixed results. The Windham et 
al. study calculated odds ratios for 4 groups stratified based on high and low ETS exposure 
and preterm and very preterm birth. The odds ratio for very preterm and preterm births, 
respectively, among mothers with high versus low ETS exposure were2.4 [95% CI: 1.0–5.3] 
and 1.5 [95% CI: 0.90–2.5].17 Two other studies, Qiu et al. and Crane et al., both evaluated 
large cohorts of over 10,000 people each and saw similar results. Qiu et al. reported an odds 
ratio of 1.98 [95% CI: 1.41–2.76]), and Crane reported 1.87 [95%CI: 1.00–3.53], 
specifically for their respective very preterm birth categories.13,16 Neither study found 
strong or significant associations for preterm or moderate preterm birth categories.13, 16 
Miyake et al. also found no association.15
Studies that combined self-reporting and biomarker measurements in their study designs 
collectively showed results that indicate a relationship between preterm birth and ETS 
exposure. One study, Ashford et al., which used maternal hair cotinine and a questionnaire to 
assess ETS exposure, reported a trending association with an odds ratio of 2.3 [95% CI: 
0.96–5.96].29 Kharrazi et al. used an extremely sensitive detection assay for serum cotinine 
measurements and observed an odds ratio for preterm birth of 1.78 [95% CI: 1.01–3.13], but 
only within the group with the highest ETS exposure confirmed by serum cotinine levels 
above 0.235 ng/ml.27 The results of Kharrazi et al. suggested that very low ETS exposure is 
not associated with preterm birth, but higher levels may be associated.27 Jaakkola et al. used 
hair nicotine to quantify ETS exposure and reported the highest odds ratio of these studies, 
6.12 [95% CI: 1.31–28.7], suggesting a strong association between ETS exposure above 
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4.00 ug/g in hair and preterm birth. However, below that threshold, the results were not 
significant.26 Jaakkola et al. also simultaneously calculated odds ratios based on self-
reported ETS exposure from the same study participants. Only those who reported ETS 
exposure both at home and at work had a statistically significant odds ratio of 8.89 [95% CI: 
1.05–75.3], while the other odds ratios were not significant.
Our assessment of studies examining the association between ETS exposure and preterm 
birth differs somewhat from a meta-analysis conducted by Leonardi-Bean et al. which 
concluded that there is no association between ETS exposure and preterm birth.30 The meta-
analysis included studies published prior to 2008 and did not include results based on the 
stratification of different prematurity categories such as very pre-term.30 In our assessment, 
we included several large studies published after 2008 that reported either a significant or 
trending association between ETS exposure and very preterm birth catagories.13,16 This 
evidence, in addition to the evidence of a positive association from several combined self-
reporting and biomarker studies, led us to interpret the evidence available thus far as being 
inconclusive.26, 29
DISCUSSION AND CONCLUSION
Preterm birth is a severe adverse health outcome that may have lifelong health implications 
for babies. Assessing possible causes of increased risk of preterm birth is essential for 
identifying public health interventions that can reduce incidence of preterm birth.6 In the 
past several decades, numerous studies have examined a potential association between ETS 
and risk of preterm birth through different strategies and approaches. The small number of 
studies that have used the approach of examining preterm birth trends before and after the 
implementation of anti-smoking legislation have largely demonstrated a significant trend of 
decreasing population-level preterm birth rates. Unfortunately, most of these studies do not 
differentiate the impact of maternal smoking from ETS in their analyses, making it difficult 
to specifically evaluate the effects of smoking bans on ETS exposure. The larger group of 
studies that have taken the approach of directly measuring maternal ETS exposure and 
calculating associations of ETS and preterm birth within particular study populations have 
had much more in conclusive results. They have utilized both self-report exposure 
assessment methods and biomarker measurements.4,20,26 Although the information revealed 
about the association between ETS exposure and preterm birth in the studies that have been 
conducted thus far serves as a starting point, more research must be done in order to clarify 
the nature of a potential association and to develop appropriate public health interventions. 
Based on this review, we propose that more studies specifically evaluating rates of preterm 
birth among non-smoking women before and after smoking bans are needed, as well as use 
of better ETS exposure assessments methods in studies measuring maternal ETS exposure.
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Framework for epidemiological study designs evaluating associations between maternal ETS 
exposure and preterm birth. Studies specifically evaluating maternal ETS exposure and risk 
of preterm birth use different methods to assess and/or quantify individual level maternal 
ETS exposure. These methods include maternal self-reporting via interviews or 
questionnaires or a combination of biomarker biochemical validation and self-reporting. 
Studies specifically evaluating ETS exposure and population level changes in preterm birth 
rate use data before and after the implementation of smoking bans.
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Change in rate of spontaneous preterm deliveries before and after these quential 
implementation of three smoking bans in Flanders, Belgium between 2006 and 2010. 
Reproduced from Impact of a stepwise introduction of smoke-free legislation on the rate of 
preterm births: analysis of routinely collected birth data, Cox, B., Martens, E., Nemery, B., 
Vangronsveld, J., and Nawrot, T. S, Vol. 346, Page f441, Copyright 2013 with permission 
from BMJ Publishing Group Ltd.7
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